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attributed to reduced density and thickness, and increased 
porosity of cortical bone. Thin trabeculae were dense, 
highly connected, and closely packed in Timp-3−/− bone. 
Furthermore, altered cortical and trabecular bone miner-
alization and increased compositional heterogeneity were 
found in Timp-3−/− bone, all being indicative of high bone 
remodeling. In conclusion, this study suggests that the 
lack of TIMP-3 is detrimental to bone development and 
maintenance.
Keywords Tissue inhibitor of metalloproteinase-3 · Bone 
strength · Bone fracture · Bone tissue mineral density · 
Bone structure · Bone composition
Introduction
Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) is one 
of the four members of the TIMP family of proteins, which 
primarily inhibits the activity of matrix metalloproteinases 
(MMP) in the extracellular matrix (ECM). The TIMPs are 
comprised of 184 to 194 amino acids, whose N-terminal 
domain allows the protein to bind to the MMPs with a 1:1 
molar stoichiometric ratio and prevents these proteinases 
from cleaving components of the ECM [1]. All the TIMPs 
inhibit MMPs, but they have different specificities. TIMP-1 
has been shown to be ineffective at inhibiting MMP-
14, MMP-16, MMP-19, and MMP-24, while TIMP-2 
and TIMP-3 are less effective than TIMP-1 at inhibiting 
MMP-3 and MMP-7 [1]. TIMP-3 is particularly effective at 
inhibiting MMP-1 and -2, and the membrane-bound MMPs 
(MMP-14, -15, -16, -17, -24, and -25) [1, 2]. Among 
the four TIMPs, TIMP-3 is the only one to additionally 
inhibit a large variety of disintegrin–metalloproteinases 
(ADAM, particularly ADAM-10, -12, -17, -28, and -33) 
Abstract Tissue inhibitor of metalloproteinases-3 
(TIMP-3) maintains a healthy extracellular matrix by 
regulating matrix metalloproteinases (MMP), disintegrin–
metalloproteinases (ADAM), and disintegrin–metallopro-
teinases with ThromboSpondin-like motifs (ADAMTS) 
activity. Currently, there is a need for a comprehensive 
understanding of the effects of TIMP-3 on the bone quality 
and integrity. In this study, we examined the mechanical, 
morphological, and compositional properties of TIMP-3 
knock out (Timp-3−/−) mouse bone. We hypothesize that 
the lack of TIMP-3 plays an important role in maintain-
ing the overall bone integrity. Mechanical properties of 
humeri, lumbar vertebrae, and femurs from Timp-3−/− mice 
were determined using 3-point bending, compression, and 
notched 3-point bending, respectively. Morphological prop-
erties of the humeral cortical and trabecular bone and the 
caudal vertebrae cortical bone were evaluated using micro-
computed tomography, while the composition of the femo-
ral cortical and trabecular bone was examined using Fou-
rier transform infrared spectroscopic imaging. Our results 
revealed that the integrity of the Timp-3−/− bone is com-
promised due to changes in its composition, structure, and 
mechanics. Reductions in the yield and ultimate load and 
stress capacity, and loss in bone fracture toughness were 
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and disintegrin–metalloproteinases with ThromboSpondin-
like motifs (ADAMTS, principally ADAMTS-1, -4, and 
-5), which help direct cell functions such as proliferation 
and migration [1, 3, 4]. Due to its role in regulating MMP, 
ADAM, and ADAMTS activity and its unique property 
to reside exclusively in the ECM, TIMP-3 may strongly 
influence hematopoiesis and ECM remodeling [5]. Stud-
ies investigating the effects of TIMP-3 on different types of 
biological tissue have determined that the lack of TIMP-3 
results in adverse tissue formation [6] and pathological 
disorders, which include periodontitis [7], oral squamous 
cell carcinoma [7], and Sorsby’s fundus dystrophy [8] in 
humans. TIMP-3-deficient mice (Timp-3−/−) further exhib-
ited increased collagen degradation [9], exacerbated inflam-
matory process [10], osteoarthritis [9], high angiogenesis 
[6], abnormal vascularization [11], dilated cardiomyopathy 
[12], increased bronchiole branching [13], severe diabetic 
symptoms [14], failed liver regeneration [10], and tumor 
growth [6, 12]. Recent studies of Timp-3−/− bone found that 
they are small in size, with compromised mass and struc-
ture, and increased number of osteoclasts [15].
This body of research shows that TIMP-3 is crucial for 
maintaining tissue integrity and suggests that the lack of 
TIMP-3 can adversely affect skeletal ECM, possibly by dis-
rupting the process of bone remodeling due to unregulated 
MMP, ADAM, and ADAMTS activity. However, there 
is a need for a more comprehensive understanding of the 
influence of TIMP-3 on bone quality and integrity. Spe-
cifically, how is TIMP-3 deficiency affecting the mechan-
ics of bone? How are structure and composition of TIMP-
3-deficient bone contributing to its mechanical properties? 
How are these affecting the function of bone? In this study, 
we analyze the bones from the Timp-3−/− mouse model 
[16], measure bone strength in compression and bending, 
and bone fracture toughness at the whole organ level. To 
explain changes in the mechanical properties of the Timp-
3−/− bone, we examine its morphology at the microscale 
length and determine the contribution of TIMP-3 to the 
bone mineral and collagen arrangement at the tissue level. 
Understanding how mechanical, structural, and composi-
tional properties of cortical and trabecular bone change in 
Timp-3−/− mice provide insights into the role of TIMP-3 in 
bone development and maintenance.
Materials and Methods
Bones from 8-week-old female mice genetically deficient 
in TIMP-3 (Timp-3−/−, N = 9) and their wild-type (WT) 
C57BL6 (N = 6) littermates were analyzed [16]. Only fresh 
frozen mice were available at the beginning of this study. 
They were obtained from a local colony that was main-
tained in accordance with the Home Office (UK) guidelines 
for the care and use of laboratory animals. Mice were stored 
at −20 °C after euthanasia. Prior to testing, bones were dis-
sected from the fresh frozen mice, cleaned of soft tissue, 
wrapped in physiological solution (PBS)-soaked gauze, and 
stored at 25 °C until testing (less than 12 h).
Bone Strength
The right humeri and L5 vertebrae from WT and Timp-
3−/− mice were loaded to fracture in three-point bend-
ing and compression, respectively, using a 50 N load cell 
(Instron 5866, Norwood, MA) [17]. Humeri were loaded at 
their mid-diaphysis in the anterior–posterior direction with 
a displacement rate of 1 μm  s−1 at 25 °C in PBS-irrigated 
conditions. Force–deflection curves were analyzed with a 
custom program (Matlab, MathWorks) to measure the bone 
stiffness (S, slope of the linear elastic deformation), yield 
force (Fy, force limit between the elastic and plastic defor-
mation, defined as the intersection point between the 0.2% 
linear offset curve and the force–displacement curve), ulti-
mate force (Fu, maximum force), work to yield (Wy, area 
under the force–displacement curve up to the yield point), 
and work to fracture (Wf, area under the force–displace-
ment curve up to bone rupture) [17].
Humeri
Prior to mechanical testing, geometrical parameters, i.e., 
mid-humeral diameter (D), cross-sectional area (CSA), and 
second moment of inertia (Imin) were measured from micro-
computed tomography (µCT) images of the humeral mid-
diaphysis (Table  1). Cortical bone was scanned along the 
long axis of humeri using SkyScan1172 (5 µm voxel size, 
55 kVp, 0.36 degrees rotation step (180 degrees angular 
Table 1  Cortical bone geometric properties of the humeri, L5 verte-
brae, and femurs of WT and Timp-3−/− mice indicate that Timp-3−/− 
bones are smaller than their WT counterparts (* indicates p < 0.05, ** 
indicates p < 0.01, and *** indicates p < 0.001)
Geometric parameter WT (N = 6) Timp-3−/− (N = 9)
Humeri
Diameter (mm) 1.47 ± 0.12 1.27 ± 0.12*
Cross-sectional area  (mm2) 1.04 ± 0.12 0.84 ± 0.20**
Second moment of area  (mm4) 0.17 ± 0.03 0.11 ± 0.04*
L5 Vertebrae
Length (mm) 2.55 ± 0.30 2.14 ± 0.39
Cross-sectional area  (mm2) 2.34 ± 0.79 2.14 ± 0.42*
Femurs
Diameter (mm) 1.62 ± 0.06 1.50 ± 0.07***
Average thickness (mm) 0.26 ± 0.02 0.21 ± 0.02***
Cross-sectional area  (mm2) 1.07 ± 0.09 0.83 ± 0.09***
Second moment of area  (mm4) 0.16 ± 0.02 0.12 ± 0.03***
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range), 200  μA current, 1600-ms exposure, performed in 
PBS-wet gauze). The measured geometrical parameters 
were used to calculate the bending stress–strain curves for 
the humeri, where the stress was:
  
where F being the force, L the loading span, d the antero-
posterior diameter, and Imin the second moment of inertia 
from the lateromedial axis (πd4⁄64); and the strain:
where δ being the deflection of the bone due to bending 
[17]. Stress–strain curves were analyzed with a custom pro-
gram (Matlab, MathWorks); and the bone elastic (Young’s) 
modulus (E, slope of the linear elastic deformation), yield 
stress (σy, stress limit between elastic and plastic strain), 
and ultimate stress (σu, maximum stress) were calculated 
using the following equations [17]:
where c is the radius along the anterior–posterior axis from 
the humeri cross-sectional centroid.
Vertebrae
Following dissection, the body and posterior elements of 
the L5 vertebrae were separated using a thin-steel razor 
blade coated in 0.05-µm diamond suspension. A dermal 
tool was then used to make the cranial and caudal ends of 
the vertebral body flat and parallel for compressive testing. 
The vertebrae were soaked in PBS and then placed in the 
compression rig where they were loaded in the cranial–cau-
dal direction. The vertebral force–deflection curves were 
analyzed with the same custom program (Matlab, Math-
Works) used to analyze the curve for the humeri; and bone 
stiffness, yield force, ultimate force, work to yield were 
measured [17]. The length of each vertebra was measured 
with a caliper prior mechanical testing, and the cross-sec-
tional area (CSA) acquired using an environmental scan-
ning electron microscope (ESEM) imaging with backscat-
tering (JEOL JSM-6380LV) in low vacuum mode (pressure 
of 15 Pa and 15 kV) (Table 1). The CSA was used to calcu-
late the compressive stress–strain curves for the vertebrae, 
where the stress was
휎 =
FLd
4Imin
,
휀 =
6훿d
L2
,
E =
SL3
48Imin
휎y =
FyLc
4Imin
휎u =
FuLc
4Imin
,
where F being the force and Ao the CSA, and the strain was
where Δl is the change in vertebral length and lo is the orig-
inal length.
The elastic modulus, yield, and ultimate stress were cal-
culated as follows [17]:
Fracture Toughness
Left femurs were micro-notched on the posterior surface of 
the mid-diaphysis with a razor blade irrigated with 0.05-
μm diamond suspension, and tested in a three-point bend-
ing configuration at a displacement rate of 1  μm/s until 
fracture, while constantly maintained under PBS hydrated 
conditions (Instron 5866, Norwood, MA) [18–20]. After a 
complete break, the fracture surface of the bones was ana-
lyzed using an ESEM with simultaneous backscattering 
(Hitachi S-3400N) in low vacuum mode (pressure of 35 Pa 
and 25 kV). From these images, geometric characteristics 
of the bone fracture surface (D, cortical thickness (t), CSA 
and Imin) at the mid-diaphysis were estimated (Table  1). 
Bone toughness was estimated with the instability method, 
thus accounting for the contributions to the toughness of 
both crack initiation and growth. Fracture toughness was 
computed using the stress-intensity solution for a through-
thickness crack in a circular thick-walled cylinder:
where Fb is a geometric constant for thick-walled cylinders, 
Pinst is the load at instability, S is the span width, Rm, Ri, and 
Ro are the mean, inner and outer radius of the bone, respec-
tively, and θinst is the instability half-crack angle [18–20].
Micro-Computed Tomography
Cortical and trabecular bone were imaged using µCT imag-
ing. Scans were taken along the long axis of the left humeri 
and CA6 vertebrae using a Scanco µCT 35 system (Scanco 
Medical, Brüttisellen, Switzerland). Scans were performed 
휎 =
F
Ao
휀 =
Δl
lo
,
E =
Slo
Ao
휎y =
Fy
Ao
휎u =
Fu
Ao
Kc = Fb
SRoPinst
휋
�
R4
o
− R
4
i
�
√
휋휃
inst
Rm,
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in 70% ethanol using 6 µm voxel size, 55 KVp, 0.36° rota-
tion step (180° angular range), and a 400-ms exposure per 
view. The Scanco µCT software (HP, DECwindows Motif 
1.6) was used for 3D reconstruction and viewing of the 
images. After 3D reconstruction, volumes were segmented 
using a global threshold of 0.4  g/c. In cortical bone, we 
analyzed the total volume (TV), the bone volume (BV), the 
bone volume density (BV/TV), porosity (Ct.Po = pores vol-
ume/TV), cortical area fraction (Ct.Ar/Tt.Ar), mean corti-
cal thickness (Ct.Th), the second moment of inertia along 
the major and minor axis (Imax and Imin), the polar moment 
of inertia (J), tissue mineral density (TMD), and bone mass 
(TMD/Ct.Po) [21, 22]. For the trabecular bone, BV, TV, 
BV/TV, connectivity density (Conn-D), trabecular number 
(Tb.N), trabecular thickness (Tb.Th), trabecular separation 
(Tb.Sp), and TMD were calculated [21].
Fourier Transform Infrared Imaging Spectroscopy
The composition and distribution of organic and inorganic 
components of the bone extracellular matrix were evalu-
ated using Fourier transform infrared imaging (FTIRI) 
spectroscopy. Right femurs were fixed in 90% ethanol and 
embedded in polymethylmethacrylate (PMMA). Spectra 
were collected in transmission with a spectral resolution of 
4 cm−1 and a spatial resolution of 6.25 µm using a Perkin 
Elmer Spotlight Imaging system from areas of ~300 µm x 
500 µm. Sections of 2 µm thickness were scanned to col-
lect five images from intact cortical and five images from 
trabecular bone. The captured spectra were processed using 
ISYS software (Spectral Dimensions, Olney, MD), and 
the atmospheric  H20 and  CO2 interference were automati-
cally subtracted from all spectra [23, 24]. A linear baseline 
from 850 to 1850  cm−1 was used to normalize the spec-
tra, then PMMA contributions were spectrally subtracted, 
and the pixels with absorbance values at 1728 cm−1 where 
masked out using ISYS software. For both cortical and 
trabecular bone, five bone compositional parameters were 
examined: the mineral-to-matrix ratio, the carbonate-to-
phosphate ratio, the mature-to-immature collagen enzy-
matic crosslinks ratio, the mineral crystallinity, and the 
acid phosphate substitution. Second derivative spectra 
were used to define the location of the peaks for intensity 
calculations. Based on these results, collagen maturity 
was defined by the relative intensity of 1660/1690  cm−1 
subbands based on the baseline amide I and amide II 
1520–1720  cm−1, crystallinity by the relative intensity of 
1030/1020 cm−1 subbands, and the acid phosphate substitu-
tion by intensities of 1028/1096 cm−1 subbands. Mineral-
to-matrix ratios were estimated by considering the areas 
under the baselined peak from 915 to 1215  cm−1 over 
the amide I area (1596–1720  cm−1); carbonate-to-phos-
phate ratio was instead the area under the peak from 850 
to 895  cm−1/915–1215  cm−1. The heterogeneity of these 
parameters was also analyzed [23–25].
Statistical Analysis
The normal distribution and homogeneity of variance of 
each variable was analyzed using the Shapiro–Wilk test and 
the Levene’s test, respectively (SPSS, IBM, Somers, NY). 
Bone strength and toughness, and morphological measures 
in Timp-3−/− and WT bone were compared using the Stu-
dent’s independent t-test for variables with normal distri-
butions and the Mann–Whitney rank test for variables with 
non-normal distributions. Measurements obtained from 
the FTIRI analysis were evaluated using analysis of vari-
ance (one-way nested ANOVA), as we had five measure-
ments per bone. P-values smaller than 0.05 were consid-
ered significant.
Results
Bone Strength
The humeri and the L5 vertebrae from Timp-3−/− mice 
exhibited significantly lower yield load, ultimate load, 
work to yield, yield stress, and ultimate stress compared to 
their WT counterparts (Table  2). Additionally, the Timp-
3−/− humeri exhibited reduced stiffness. No statistically sig-
nificant difference between Timp-3−/− and WT mouse bone 
was found in the elastic modulus.
Fracture Toughness
Fracture toughness testing revealed that the toughness of 
the Timp-3−/− femurs was reduced by a third when com-
pared to the healthy WT femurs (Table 2).
Micro-Computed Tomography
Timp-3−/− bone had a different morphology compared to 
WT bone (Tables  3, 4). Timp-3−/− cortical bone of both 
humeri and vertebrae exhibited significantly lower TV, BV, 
BV/TV, Ct.Ar/Tt.Ar, Ct.Th, Imax, Imin, and J, but a greater 
Ct.Po, compared to WT bone (Table 3). Timp-3−/− trabec-
ular bone from the humeri had a significantly lower TV, 
Tb.Th, and Tb.Sp compared to normal counterparts, with 
a greater BV/TV, Conn-D, and Tb.N, than in WT bone 
(Table  4). Timp-3−/− cortical and trabecular bone exhib-
ited lower TMD in the humeri but not in the vertebrae. 
Bone mass in the Timp-3−/− humeri and vertebrae was also 
reduced when compared to the corresponding WT bone.
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Fourier Transform Infrared Imaging Spectroscopy
Analysis of the FTIRI images comparing the Timp-
3−/− bones to their respective counterparts revealed a 
significantly lower carbonate-to-phosphate ratio and a 
significantly greater acid phosphate level in the Timp-
3−/− cortical and trabecular bone (Fig. 1; Table 5). Timp-
3−/− trabecular bone also showed an increase in the enzy-
matic collagen crosslinking ratio.
Heterogeneity of the collagen crosslinking ratio was sig-
nificantly higher in Timp-3−/− cortical and trabecular bone 
(Table  5). Furthermore, Timp-3−/− trabecular bone exhib-
ited a significantly greater heterogeneity of the carbonate-
to-phosphate ratio and a significantly lower heterogeneity 
of the mineral crystallinity compared to WT bone. Neither 
the mineral-to-matrix ratio nor its heterogeneity differed 
significantly when the two genotypes were compared.
Discussion
In this study, we investigated the influence of the TIMP-3 
gene on bone quality and mechanical integrity of the skel-
eton of the Timp-3−/− mouse model. Our results prove that 
TIMP-3 is fundamental for regulating and maintaining the 
correct composition, structure, and mechanics of bone. 
Understanding how TIMP-3 affects bone integrity is of a 
great biological and clinical interest for regulating skeletal 
homeostasis and development.
Our testing revealed compromised mechanical properties 
of the long bones and vertebrae of the Timp-3−/− mice. Infe-
rior yield and ultimate loads were found in Timp-3−/− bone. 
Also, stiffness, work to yield, yield and ultimate stress, and 
fracture toughness were reduced in Timp-3−/− long bone. 
Young’s modulus values for the Timp-3−/− bone demon-
strated a tendency to decrease, but the high variance of 
these values resulted in no statistical significance compared 
with WT bone. The decrease in the mechanical proper-
ties of bone we observed in this study is in agreement with 
previous works that found compromised tissue quality and 
Table 3  Structural analysis of 
the cortical bone in the humeri 
and CA6 vertebrae of WT and 
Timp-3−/− bone indicates that 
the TIMP-3 deficiency alters the 
structural properties of cortical 
bone
Both the Timp-3−/− humeri and the CA6 vertebrae had reduced total volume (TV), bone volume (BV), 
bone volume density (BV/TV), thickness (Ct.Th), moments of inertia (Imax, Imin, J), tissue mineral density 
(TMD), and overall bone mass
Both types of bones in TIMP-3 deficient mice also exhibited higher cortical porosity (Ct.Po)
* indicates p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001
µCT parameter Cortical bone
Humeri Vertebrae
WT (N = 6) Timp-3−/− (N = 9) WT (N = 6) Timp-3−/− (N = 9)
TV  (mm3) 1.41 ± 0.08 1.11 ± 0.07*** 1.20 ± 0.11 1.01 ± 0.09*
BV  (mm3) 0.83 ± 0.04 0.6 ± 0.04*** 0.79 ± 0.06 0.56 ± 0.04***
BV/TV (%) 59 ± 1 54 ± 2*** 66 ± 2 56 ± 3***
Ct.Po (%) 5.04 ± 1.42 8.51 ± 0.51** 7 ± 1 16 ± 5**
Ct.Ar/Tt.Ar (%) 59 ± 1 54 ± 2*** 66 ± 2 56 ± 3***
Ct.Th (mm) 0.20 ± 0.00 0.15 ± 0.01*** 0.18 ± 0.01 0.11 ± 0.02**
Imax  (mm4) 0.09 ± 0.01 0.05 ± 0.07*** 0.13 ± 0.03 0.09 ± 0.02**
Imin  (mm4) 0.06 ± 0.01 0.03 ± 0.01*** 0.12 ± 0.02 0.07 ± 0.01***
J  (mm4) 0.14 ± 0.01 0.08 ± 0.01*** 0.26 ± 0.05 0.16 ± 0.03**
TMD (mg/cm− 3) 1124.91 ± 4.83 1063.95 ± 16.41*** 938.49 ± 12.62 892.49 ± 72.33
Bone Mass (mg) 236.50 ± 56.35 125.35 ± 7.83** 132.48 ± 12.07 62.08 ± 25.64***
Table 4  Structural analysis of the trabecular bone in the humerus of 
WT and Timp-3−/− bone
Bone volume density (BV/TV), connectivity density (Conn.Dens), 
and trabecular number (Tb.N) were significantly increased in the tra-
becular bone of the TIMP-3-deficient mice
Timp-3−/− trabecular bone had also a significant decrease in the total 
volume (TV), trabecular thickness (Tb.Th), trabecular separation (Tb.
Sp), and tissue mineral density (TMD)
* indicates p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001
µCT parameter Humeral trabecular bone
WT (N = 6) Timp-3−/− (N = 9)
TV  (mm3) 1.57 ± 0.05 1.16 ± 0.18***
BV  (mm3) 0.19 ± 0.02 0.16 ± 0.03
BV/TV (%) 12 ± 1 14 ± 1*
Conn-Dens.  (mm−3) 294.13 ± 38.84 552.83 ± 113.67***
Tb.N  (mm−1) 4.47 ± 0.32 6.15 ± 0.67***
Tb.Th (mm) 0.04 ± 0.00 0.03 ± 0.00***
Tb.Sp (mm) 0.23 ± 0.02 0.16 ± 0.02***
TMD  (mm−3) 914.41 ± 8.24 873.81 ± 18.99**
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function in the respiratory [26], cardiovascular [27], liver 
[10], and musculoskeletal tissue of Timp-3−/− mice [15].
Alterations in the structure and composition of the 
Timp-3−/− bone mice can explain the deficiencies observed 
in the mechanical properties of the Timp-3−/− bone. Our 
µCT analysis of the bone architecture and mineral density 
revealed that TIMP-3 deficiency alters both cortical and 
trabecular bone structure and compromises bone mass. 
The morphological analysis of Timp-3−/− cortical bone 
revealed a significant decrease in the bone volume, with 
thinner cortices and higher canal porosity compared with 
WT bone. Timp-3−/− bones were smaller, with a reduced 
Fig. 1  FTIRI of cortical and trabecular bone of one representative femur from WT and one from Timp-3−/− bone (* indicates p < 0.05, ** indi-
cates p < 0.01, and *** indicates p < 0.001)
Table 5  FTIR parameters for cortical and trabecular bone of WT and Timp-3−/− femurs
Measurements of the WT and Timp-3−/− cortical bone revealed that there was a 12.7% reduction of carbonate substitution in the hydroxyapa-
tite crystals, a 7.4% increase in the amount of acid phosphate, and a 23.5% increase in the heterogeneity of the mature-to-immature collagen 
crosslinking ratio in the Timp-3−/− bone matrix. The FTIRI measurements of the WT and Timp-3−/− trabecular bone demonstrated a 37.2% 
decrease in carbonate substitution in the hydroxyapatite crystals, an 8.8% increase in the collagen enzymatic crosslinking ratio, and an 11.1% 
increase in the acid phosphate ratio
Analysis of the compositional heterogeneity of Timp-3−/− trabecular bone demonstrated a 21.2% increase in the carbonate-to-phosphate ratio 
heterogeneity, a 41% increase in the collagen enzymatic crosslinking ratio heterogeneity, and a 14.1% decrease in the crystallinity heterogeneity 
of the hydroxyapatite crystals in the matrix
* indicates p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001
FTIR parameter Cortical bone Trabecular bone
WT (N = 6) Timp-3−/− (N = 9) WT (N = 6) Timp-3−/− (N = 9)
Mineral/matrix ratio 6.66 ± 0.56 6.97 ± 0.89 5.57 ± 0.45 5.87 ± 0.41
Carbonate/phosphate ratio  (10− 3) 6.20 ± 0.50 5.50 ± 0.80* 5.90 ± 0.80 4.30 ± 0.50***
Crosslink ratio 3.77 ± 0.13 3.87 ± 0.19 3.96 ± 0.20 4.35 ± 0.24**
Crystallinity 1.20 ± 0.03 1.20 ± 0.04 1.15 ± 0.02 1.16 ± 0.03
Acid phosphate 0.49 ± 0.02 0.52 ± 0.05* 0.63 ± 0.04 0.71 ± 0.05**
Mineral/matrix heterogeneity 2.14 ± 0.59 2.27 ± 0.61 2.51 ± 0.49 2.81 ± 0.65
Carbonate/phosphate heterogeneity  (10− 3) 2.10 ± 0.1 2.20 ± 0.20 2.60 ± 0.30 3.30 ± 0.40***
Crosslink heterogeneity 0.42 ± 0.03 0.55 ± 0.10** 0.50 ± 0.08 0.85 ± 0.30*
Crystallinity heterogeneity  (10− 2) 12.97 ± 1.53 12.42 ± 2.05 19.07 ± 1.71 16.72 ± 0.81**
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cross-sectional area and altered geometry (Imax, Imin, and 
J), in agreement with previous studies conducted on the 
tibiae of the same mouse strain [15]. The increase in the 
Timp-3−/− cortical bone porosity due to the vascular chan-
nels is also in agreement with the increase in angiogen-
esis typical of these bones [6]. TIMP-3, as all the other 
TIMPs, is a strong inhibitor of angiogenesis. In particu-
lar, TIMP-3 binds directly to VEGF receptor2, blocking 
the action of VEGF on endothelial cells [1]. Furthermore, 
MMP-9, regulated by TIMP-3 and produced by osteoclasts, 
has been identified as a stimulator for angiogenesis in the 
bone microenvironment [28]. Our results, therefore, sug-
gest that a deficiency in TIMP-3 may directly block inhi-
bition of angiogenesis and further generate an excess of 
MMP-9, which in turn results in increased bone angiogen-
esis and vascularization, thus having an effect on the anti-
angiogenic activity of the other TIMPs. High intracortical 
vascular porosity is known to reduce bone resistance to 
fracture [29] by increasing the stress concentrations around 
the holes within the bone [22] and by increasing the veloc-
ity of crack propagation [19]. Therefore, high bone poros-
ity reduces the mechanical properties of bone and helps 
explain the decrease in fracture toughness observed here in 
the Timp-3−/− femurs.
Prior research on bone demonstrated that cortical thin-
ning and increased porosity occur when the rate of bone 
remodeling is altered [30, 31]. In agreement with that, a 
recent histological analysis of Timp-3−/− bone has found 
an increased osteoclasts number in TIMP-3-deficient bone, 
with no changes in the osteoblasts number, and no changes 
in the growth plate area [15]. Thus, it is possible that due 
to the lack of TIMP-3 in the bone, there is an unregulated 
MMP, ADAM, and ADAMTS activity in the tissue that 
leads to an increase in bone remodeling, which may, in 
turn, decrease cortical thickness and increase bone poros-
ity. Although we did not directly measure bone remod-
eling in this study, mainly because only fresh frozen mice 
were available for this study, the possible increase in bone 
remodeling of the Timp-3−/− bone is suggested by the 
changes in composition of these bones analyzed in this 
study. Our FTIRI analysis of the Timp-3−/− femurs indi-
cates that their cortical and trabecular bone has less car-
bonate, more acid phosphate, and a more heterogeneous 
distribution of mature-to-immature enzymatic collagen 
crosslinks. All these parameters are indicative of increased 
remodeling in the bone [32–34]. High bone remodeling 
indeed reduces the carbonate content in the bone, as car-
bonate is typically where the tissue is not turned over [32], 
and increases the acid phosphate in the areas of new bone 
formation and mineral deposition [35]. This is further con-
firmed by the increase in the heterogeneity of the collagen 
crosslinking ratio, previously associated with increased 
bone remodeling [36]. Carbonate substitutes for phosphate 
ions in bone (B-type carbonate); thus, the phosphate envi-
ronment of the mineral is distorted [37]. An increase in 
crystallinity (crystal size and perfection) would be expected 
to parallel a loss of carbonate; however, no statistically sig-
nificant change was seen (1.15 vs 1.16), perhaps because 
the crystallinity parameter, based on intensities, is less sen-
sitive than the peak area ratio used for carbonate-to-phos-
phate ratio. Alternatively, since increased acid phosphate 
substitution (due to new bone formation) would decrease 
crystallinity, combined these two changes contribute to the 
constant crystallinity value. Our study thus suggests that an 
increased remodeling in the Timp-3−/− cortical bone cre-
ates geometric changes at the bone nanoscale level with 
more immature (smaller and less perfect) hydroxyapatite 
crystals and high tissue heterogeneity, which in turn affect 
the bone architecture at the microscale level and reduce 
the mass, strength, and toughness of the bone at the organ 
level. Also, at the trabecular level, changes in the composi-
tion of the Timp-3−/− bone result in the altered micro-archi-
tecture, characterized by a reduced total bone volume with 
an increased volume density and more, thinner, highly con-
nected, and closely packed trabeculae: a typical configura-
tion of a bone with high remodeling. Interestingly, the tra-
becular configuration we observed in the Timp-3−/− mice is 
not due to improper growth plate cartilage degradation [15] 
rather our results suggest collagenases are predominantly 
responsible for altered Timp-3−/− bone architecture through 
imbalanced bone remodeling.
Previous studies examining bone matrix in the pres-
ence of increased MMP-1, -2, -8, -9, -14, and -16 activities 
found a higher bone remodeling due to excessive collagen 
degradation, generating skeletal abnormalities and deformi-
ties [28, 38–41]. Both ADAMs and ADAMTS could also 
influence the rate of bone remodeling [42–44]. In particu-
lar, ADAM-10 and ADAM-12 play a role in bone in influ-
encing human peripheral blood mononuclear cells to dif-
ferentiate into osteoblasts and osteoclasts [42]. Inhibition 
of ADAM-15 activity can increase osteoblast proliferation 
and function and result in higher bone mass [43]. Further-
more, ADAMTS-18 deletion significantly correlated to 
increased osteoclastogenesis and osteoblastogenesis [44]. It 
is also possible that common substrates between the TIMPs 
allow for other TIMPs to regulate metalloproteinases activ-
ity in absence of TIMP-3. For example, the increased bone 
formation with highly connected and closely spaced tra-
beculae we observed in the Timp-3−/− mice was previously 
found in the skeleton of MMP-13 Null mice [45]. MMP-13 
plays a role in remodeling the cartilage matrix in endochon-
dral ossification, vascularization, and chondroclast recruit-
ment, and the change observed in trabecular bone has been 
related to improper cartilage degradation with hypertrophic 
chondrocytes and osteoblasts due to the lack of MMP-
13 [39, 45]. With a TIMP-3 deficiency, we would expect 
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instead an overabundance of MMP-13. Thus, it is possi-
ble that either TIMP-3 is less effective than other TIMPs 
in regulating MMP-13 or that the actions of TIMP-3 are 
taken over by other TIMPs and without this redundancy, 
the phenotype of the Timp-3−/− mice could even be more 
severe. Future studies are required to elucidate the rela-
tionship between the TIMPs and MMPs, ADAMs, and 
ADAMTSs, to reveal which enzymes are directly involved 
in the changes observed in the Timp-3−/− bone.
This study has some limitations that need to be pointed 
out. First, because the animals were not double-labeled, we 
were unable to do histomorphometry to confirm the altered 
remodeling. Secondly, we did not measure the composition 
of all bones (but only femurs), nor of an entire bone, but 
rather selected intact cortical bone and intact trabeculae 
and considered their averages and distributions, rather than 
a unique site (e.g., adjacent to newly deposited bone). This, 
in a sense, is analogous to measuring the chemical compo-
sition of multiple aliquots of cortical or cancellous bones 
from several different animals, thus the need to use a nested 
statistical analysis to account for measurements from the 
same bones.
Conclusions
This study demonstrates that TIMP-3 plays a fundamen-
tal role in determining and maintaining bone quality and 
integrity, regulating both cortical and trabecular bone. 
The lack of TIMP-3 generates smaller bones with thin 
and highly porous cortex and dense, highly connected and 
closely packed, thin trabeculae. Composition is also altered 
in Timp-3−/− bone, with smaller, immature, and less per-
fect crystals. This compromised structure and composition 
results in the inferior mechanical properties of the Timp-
3−/− bone. This study therefore proves that TIMP-3 is a 
critical component for maintaining healthy bone, enabling 
its matrix to properly mature, generate, and maintain opti-
mal compositional, structural, and mechanical properties. 
Our results open the way to further studies for a thorough 
investigation of the relations between TIMP-3, and MMP, 
ADAM, ADAMTS activity, and bone properties, and their 
relation with the compromised quality of other tissue in 
Timp-3−/− mice. These future studies will eventually lead to 
the development of treatments for diseases related to abnor-
mal TIMP-3, MMPs, ADAMs, and ADAMTSs activity, 
with the ultimate aim to improve tissue quality and quan-
tity, and regain healthy mechanical properties in bone as 
well as in other body tissues.
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